These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 17100022)

  • 1. Exposed CSF shunts: the naked truth about shunt infections.
    Sciubba DM
    South Med J; 2006 Oct; 99(10):1055-6. PubMed ID: 17100022
    [No Abstract]   [Full Text] [Related]  

  • 2. Treatment of cerebrospinal fluid shunt infections: a decision analysis.
    Schreffler RT; Schreffler AJ; Wittler RR
    Pediatr Infect Dis J; 2002 Jul; 21(7):632-6. PubMed ID: 12237594
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Management of shunt infections: a multicenter pilot study.
    Kestle JR; Garton HJ; Whitehead WE; Drake JM; Kulkarni AV; Cochrane DD; Muszynski C; Walker ML
    J Neurosurg; 2006 Sep; 105(3 Suppl):177-81. PubMed ID: 16970229
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of an institutional guideline for the treatment of cerebrospinal fluid shunt-associated infections.
    von der Brelie C; Simon A; Gröner A; Molitor E; Simon M
    Acta Neurochir (Wien); 2012 Sep; 154(9):1691-7. PubMed ID: 22454037
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Ventriculo-atrial shunt infection. Necessity of cardiovascular consultation and surgery in two cases].
    Abad C; Justo García I; Feijoo J; Ponce G
    An Med Interna; 2006 Nov; 23(11):559-60. PubMed ID: 17330358
    [No Abstract]   [Full Text] [Related]  

  • 6. Infections associated with cerebrospinal fluid shunts for hydrocephalus.
    Bayston R
    Minerva Pediatr; 1992 Oct; 44(10 Suppl 1):43-51. PubMed ID: 1470074
    [No Abstract]   [Full Text] [Related]  

  • 7. Conservative management of patients with cerebrospinal fluid shunt infections.
    Brown EM; Edwards RJ; Pople IK
    Neurosurgery; 2006 Apr; 58(4):657-65; discussion 657-65. PubMed ID: 16575329
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Factors contributing to the medical costs of cerebrospinal fluid shunt infection treatment in pediatric patients with standard shunt components compared with those in patients with antibiotic impregnated components.
    Sciubba DM; Lin LM; Woodworth GF; McGirt MJ; Carson B; Jallo GI
    Neurosurg Focus; 2007 Apr; 22(4):E9. PubMed ID: 17613199
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A reappraisal of contributing factors leading to shunt infection.
    Khan I; Burhan M; Nadeem M
    J Ayub Med Coll Abbottabad; 2009; 21(1):66-8. PubMed ID: 20364744
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epidemiology, diagnosis, treatment, and prevention of cerebrospinal fluid shunt infections.
    Bayston R
    Neurosurg Clin N Am; 2001 Oct; 12(4):703-8, viii. PubMed ID: 11524291
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hospital costs associated with shunt infections in patients receiving antibiotic-impregnated shunt catheters versus standard shunt catheters.
    Attenello FJ; Garces-Ambrossi GL; Zaidi HA; Sciubba DM; Jallo GI
    Neurosurgery; 2010 Feb; 66(2):284-9; discussion 289. PubMed ID: 20087127
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Management of complicated shunt infections: a clinical report.
    James HE; Bradley JS
    J Neurosurg Pediatr; 2008 Mar; 1(3):223-8. PubMed ID: 18352767
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Antibiotic therapy of infected cerebrospinal fluid in hydrocephalus treated by a shunt].
    Isla Guerrero A; Peña García P; Ortega V; Alvarez Ruiz F; Moriche Carretero M; Paredes García E; García Blázquez M
    An Esp Pediatr; 1988 Dec; 29(6):435-9. PubMed ID: 3072889
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cerebrospinal fluid shunt infections in children.
    Ronan A; Hogg GG; Klug GL
    Pediatr Infect Dis J; 1995 Sep; 14(9):782-6. PubMed ID: 8559628
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reduction in shunt infection using antibiotic impregnated CSF shunt catheters: an Australian prospective study.
    Pattavilakom A; Xenos C; Bradfield O; Danks RA
    J Clin Neurosci; 2007 Jun; 14(6):526-31. PubMed ID: 17430776
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A plasma polymerization technique to overcome cerebrospinal fluid shunt infections.
    Cökeliler D; Caner H; Zemek J; Choukourov A; Biederman H; Mutlu M
    Biomed Mater; 2007 Mar; 2(1):39-47. PubMed ID: 18458432
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Successful antibiotic eradication of Streptococcus pneumoniae infection of a ventriculoatrial shunt.
    Orvin K; Bilavsky E; Weiner E; Shouval DS; Amir J
    Int J Infect Dis; 2009 May; 13(3):e101-3. PubMed ID: 18948047
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevention and management of internal cerebrospinal fluid shunt infections.
    Dawod J; Tager A; Darouiche RO; Al Mohajer M
    J Hosp Infect; 2016 Aug; 93(4):323-8. PubMed ID: 27107616
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical and economic consequences of antibiotic-impregnated cerebrospinal fluid shunt catheters.
    Eymann R; Chehab S; Strowitzki M; Steudel WI; Kiefer M
    J Neurosurg Pediatr; 2008 Jun; 1(6):444-50. PubMed ID: 18518694
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characteristics and treatment outcome of cerebrospinal fluid shunt-associated infections in adults: a retrospective analysis over an 11-year period.
    Conen A; Walti LN; Merlo A; Fluckiger U; Battegay M; Trampuz A
    Clin Infect Dis; 2008 Jul; 47(1):73-82. PubMed ID: 18484878
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.